RF
AMGN icon

Robbins Farley’s Amgen AMGN Stock Holding History

Robbins Farley’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15
Closed -$3.63K – 164
2023
Q1 		$3.63K Hold
15
– – ﹤0.01% 145
2022
Q4 		$3.94K Buy
+15
New +$4.02K ﹤0.01% 124
2021
Q3 		– Sell
-50
Closed -$12K – 167
2021
Q2 		$12K Sell
50
-10
-17% -$2.46K 0.01% 54
2021
Q1 		$15K Buy
+60
New +$14.3K 0.01% 90

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Robbins Farley's AMGN Position: Q2 2023 in Review

Robbins Farley sold out of Amgen (AMGN) in Q2 2023, closing a stake of 15 shares — an estimated $3.63K sold.

Robbins Farley first reported a position in AMGN in Q1 2021 and held it in 4 quarters. The position peaked at $15K in Q1 2021. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Robbins Farley reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Robbins Farley sold 15 Amgen shares in Q2 2023, an estimated $3.63K.
  • Robbins Farley first reported a position in Amgen in Q1 2021 and held it in 4 quarters.
  • Robbins Farley's Amgen position peaked at $15K in Q1 2021.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Robbins Farley's 13F filing for Q2 2023, filed 7 Aug 2023.